IOWHInstitute for One World Health (San Francisco, CA)
References in periodicals archive ?
As a result, IOWH has agreed to sponsor all development activities, including production of drug substance, IND-enabling safety studies, and Phase I clinical trials.
Victoria Hale, CEO and founder of IOWH stated: "IOWH drug development scientists are very excited to enable the early clinical development of CRA-3316 for Chagas' Disease and provide the needed proof of concept for targeting cysteine proteases for other parasitic diseases.
IOWH is a non-profit company of pharmaceutical scientists whose mission is to develop affordable, essential new drugs for neglected diseases throughout the world.